MannKind and Rose Pharma Partner on Inhaled GLP-1
Danbury, Connecticut, USA, September 9, 2026 MannKind Corporation and Rose Pharma Inc. have entered into a licensing and collaboration...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Danbury, Connecticut, USA, September 9, 2026 MannKind Corporation and Rose Pharma Inc. have entered into a licensing and collaboration...
Dublin, Ireland, September 9, 2026 LUMA Vision has secured additional U.S. FDA clearance for its VERAFEYEâ„¢ procedural intelligence platform,...
Cambridge, Massachusetts, USA, September 8, 2026 LabCentral has launched The Loop, a new program designed to help international biotech...
Shanghai and Hong Kong, PRC, August 24, 2026 Antengene Corporation Limited has reported its first-ever profitable period, alongside continued...
Shanghai, China,August 20, 2026 Henlius announced its 2026 interim results, highlighting continued financial growth, expanding global commercialization, and progress...
Needham, Massachusetts, USA,August 20, 2026 Evolved By Nature, Inc. announced that its programmable peptide platform has been used in...
Rockville, Maryland and Shanghai, China, August 17, 2026 AbelZeta Pharma, Inc. announced that the U.S. Food and Drug Administration...
Bedford, Massachusetts, August 14, 2026 Lantheus Holdings, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved...
San Diego, California, August 14, 2026 BioSapien Inc., a biotechnology company developing localized drug-delivery technologies for cancer treatment, has...
VALENCIA, Spain, July 23, 2026 ARTHEx Biotech has announced the publication of groundbreaking preclinical data demonstrating that its investigational...
